- ►diabetesjournals.org A Hansen, BL Johansson, J Wahren, H von … - Diabetes, 2002 - Am Diabetes Assoc Myocardial dysfunction, perfusion abnormalities, and the extent to which these
abnormalities may be reversed by C-peptide administration was assessed in type 1
diabetic patients. Eight patients were studied before and during a ... Cited by 60 - Related articles - BL Direct - All 5 versions
- ►physiology.org BL Johansson, J Wahren, J Pernow - American Journal of Physiology- Endocrinology And …, 2003 - Am Physiological Soc Proinsulin C-peptide has been shown to increase muscle blood flow in type 1
diabetic patients. The underlying mechanism is not fully understood. The aim of
this study was to evaluate if the vasodilator effect of C-peptide is ... Cited by 26 - Related articles - BL Direct - All 4 versions
[CITATION] Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with type …
K Ekberg, T Brismar, BL Johansson, B Jonsson … - Diabetes, 2003 - Am Diabetes Assoc Studies have demonstrated that proinsulin C-peptide stimulates the activities of
Na + ,K + -ATPase and endothelial nitric oxide synthase, both of which are
enzyme systems of importance for nerve function and known to be deficient ... Cited by 106 - Related articles - BL Direct - All 5 versions
- ►onlinejacc.org ZY Fang, S Yuda, V Anderson, L Short, C … - Journal of the American College of Cardiology, 2003 - Elsevier We studied 186 patients with normal ejection fraction and no evidence of CAD: 48
with diabetes mellitus only (DM group), 45 with LVH only (LVH group), 45 with
both diabetes and LVH (DH group), and 48 normal controls. Peak strain and ... Cited by 176 - Related articles - BL Direct - All 12 versions
- ►physiology.org BL Johansson, J Sundell, K Ekberg, C Jonsson … - American Journal of Physiology- Endocrinology And …, 2004 - Am Physiological Soc Patients with type 1 (insulin-dependent) diabetes show reduced skeletal muscle
blood flow and coronary vasodilatory function despite intensive insulin therapy
and good metabolic control. Administration of proinsulin C-peptide ... Cited by 25 - Related articles - BL Direct - All 4 versions
BL Johansson, K Borg, E Fernqvist-Forbes, A … - Diabetic Medicine, 2000 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 102 - Related articles - BL Direct - All 6 versions
J Shafqat, L Juntti-Berggren, Z Zhong, K … - Cellular and Molecular Life Sciences, 2002 - Springer Abstract. Based on the findings that proinsulin C-pep- tide binds specifically
to cell membranes, we investigated the effects of C-peptide and related
molecules on the in- tracellular Ca 2+ concentration ([Ca 2+ ] i ) in human ... Cited by 29 - Related articles - BL Direct - All 3 versions
- ►nih.gov [PDF] T Forst, T Kunt, T Pohlmann, K Goitom, M … - Journal of Clinical Investigation, 1998 - pubmedcentral.nih.gov 19 insulin-dependent diabetes mellitus (IDDM) patients participated in a
randomized double-blind crossover inves- tigation to investigate the impact of
human C-peptide on skin microvascular blood flow. The investigation was ... Cited by 88 - Related articles - BL Direct - All 6 versions
- ►ksu.edu.sa [PDF] NM Al-Rasheed, F Meakin, EL Royal, AJ … - Diabetologia, 2004 - Springer Aims/hypothesis. Proinsulin C-peptide is generally be- lieved to be inert
without any appreciable biological functions. However, it has been shown to
modulate a variety of cellular processes important in the patho- physiology ... Cited by 21 - Related articles - BL Direct - All 8 versions
